Correction: Considerations in the management of hereditary angioedema due to C1-INH deficiency in women of childbearing age.
作者信息
Hsu Florence Ida, Lumry William, Riedl Marc, Tachdjian Raffi
机构信息
Yale University School of Medicine, New Haven, CT, USA.
AARA Research Center, Dallas, TX, USA.
出版信息
Allergy Asthma Clin Immunol. 2022 Sep 3;18(1):81. doi: 10.1186/s13223-022-00714-x.
Abstract
摘要
相似文献
1
Correction: Considerations in the management of hereditary angioedema due to C1-INH deficiency in women of childbearing age.更正：育龄期C1-INH缺乏所致遗传性血管性水肿的管理考量
Allergy Asthma Clin Immunol. 2022 Sep 3;18(1):81. doi: 10.1186/s13223-022-00714-x.
2
Long-term efficacy and safety of subcutaneous C1-inhibitor in women with hereditary angioedema: subgroup analysis from an open-label extension of a phase 3 trial.皮下注射C1抑制剂治疗遗传性血管性水肿女性患者的长期疗效和安全性：一项3期试验开放标签扩展研究的亚组分析
Allergy Asthma Clin Immunol. 2020 Feb 4;16:8. doi: 10.1186/s13223-020-0409-3. eCollection 2020.
3
Hereditary angioedema with normal C1-INH (HAE type III).遗传性血管性水肿伴正常 C1-INH（HAE 型 III）。
J Allergy Clin Immunol Pract. 2013 Sep-Oct;1(5):427-32. doi: 10.1016/j.jaip.2013.06.004. Epub 2013 Aug 2.
4
Diagnosis, Course, and Management of Angioedema in Patients With Acquired C1-Inhibitor Deficiency.获得性 C1 抑制剂缺乏症患者血管性水肿的诊断、病程和治疗。
J Allergy Clin Immunol Pract. 2017 Sep-Oct;5(5):1307-1313. doi: 10.1016/j.jaip.2016.12.032. Epub 2017 Mar 9.
5
Lack of increased prevalence of immunoregulatory disorders in hereditary angioedema due to C1-inhibitor deficiency.遗传性血管性水肿患者因 C1 抑制剂缺乏而导致免疫调节紊乱的发生率并未增加。
Clin Immunol. 2011 Oct;141(1):58-66. doi: 10.1016/j.clim.2011.05.004. Epub 2011 May 19.
6
International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency.关于C1抑制剂缺乏的遗传性血管性水肿儿科患者诊断和管理的国际共识。
Allergy. 2017 Feb;72(2):300-313. doi: 10.1111/all.13001. Epub 2016 Sep 8.
7
Idiopathic Nonhistaminergic Acquired Angioedema Versus Hereditary Angioedema.特发性非组胺性获得性血管性水肿与遗传性血管性水肿。
J Allergy Clin Immunol Pract. 2018 Jul-Aug;6(4):1205-1208. doi: 10.1016/j.jaip.2018.04.018. Epub 2018 Apr 30.
8
Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey.获得性血管性水肿与遗传性血管性水肿（I/II型）的比较：依卡替班疗效调查结果
Clin Exp Immunol. 2017 Apr;188(1):148-153. doi: 10.1111/cei.12910. Epub 2017 Feb 9.
9
C1 Inhibitor Activity and Angioedema Attacks in Patients with Hereditary Angioedema.遗传性血管性水肿患者的C1抑制剂活性与血管性水肿发作
J Allergy Clin Immunol Pract. 2020 Mar;8(3):892-900. doi: 10.1016/j.jaip.2019.10.003. Epub 2019 Oct 23.
10
The safety of treatments for angioedema with hereditary C1 inhibitor deficiency.遗传性C1抑制剂缺乏所致血管性水肿治疗的安全性
Expert Opin Drug Saf. 2015;14(11):1725-36. doi: 10.1517/14740338.2015.1094053. Epub 2015 Oct 1.
本文引用的文献
1
Considerations in the management of hereditary angioedema due to C1-INH deficiency in women of childbearing age.育龄期女性因C1-INH缺乏所致遗传性血管性水肿的管理考量
Allergy Asthma Clin Immunol. 2022 Jul 13;18(1):64. doi: 10.1186/s13223-022-00689-9.
Zotero 插件